Philippe Clézardin (Philippe Clezardin)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Cancers

Oncogene

Cancer research

British journal of cancer

INSERM/University of Sheffield

INSERM (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM/University of Sheffield Jan 01 2017

United Kingdom

Head / Professor in Bone Oncology :: International Associated Laboratory

INSERM Jan 01 2011

France

Head of U1033 :: Research Unit U1033

Education History

INSERM Jan 01 1987

France

PHD :: Research Unit U1033

Publications

Farah Ramadan, Raya Saab, Farah Ghamloush, Rita Khoueiry, Zdenko Herceg, Ludovic Gomez, Bassam Badran, Philippe Clézardin, Nader Hussein, Pascale A Cohen, Sandra E Ghayad
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma. Cancers 16 (9) (2024)
Farah Ramadan, Raya Saab, Farah Ghamloush, Rita Khoueiry, Zdenko Herceg, Ludovic Gomez, Bassam Badran, Philippe Clézardin, Nader Hussein, Pascale A Cohen, Sandra E Ghayad
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma. Cancers 16 (9) (2024)
Farah Ramadan, Raya Saab, Farah Ghamloush, Rita Khoueiry, Zdenko Herceg, Ludovic Gomez, Bassam Badran, Philippe Clézardin, Nader Hussein, Pascale A Cohen, Sandra E Ghayad
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma. Cancers 16 (9) (2024)
Margherita Puppo, Manoj Kumar Valluru, Martine Croset, Davide Ceresa, Michele Iuliani, Ashrin Khan, Julien Wicinski, Emmanuelle Charafe-Jauffret, Christophe Ginestier, Francesco Pantano, Penelope Dawn Ottewell, Philippe Clézardin
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness. British journal of cancer (2023)
Hao Xu, Marie-Hélène Lafage-Proust, Lamia Bouazza, Sandra Geraci, Philippe Clézardin, Bernard Roche, Françoise Peyrin, Max Langer
Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CT. Cancers 14 (14) (2022)
Margherita Puppo, Mariam Jaafar, Jean-Jacques Diaz, Virginie Marcel, Philippe Clézardin
MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential. Cancers 15 (1) (2022)
Pia Fahmé, Farah Ramadan, Diep Tien Le, Kieu-Oanh Nguyen Thi, Sandra E Ghayad, Nader Hussein, Chantal Diaz, Martine Croset, Philippe Clézardin, Pascale A Cohen
The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression. Cancers 14 (24) (2022)
Pia Fahmé, Farah Ramadan, Diep Tien Le, Kieu-Oanh Nguyen Thi, Sandra E Ghayad, Nader Hussein, Chantal Diaz, Martine Croset, Philippe Clézardin, Pascale A Cohen
The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression. Cancers 14 (24) (2022)
Margherita Puppo, Mariam Jaafar, Jean-Jacques Diaz, Virginie Marcel, Philippe Clézardin
MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential. Cancers 15 (1) (2022)
Margherita Puppo, Mariam Jaafar, Jean-Jacques Diaz, Virginie Marcel, Philippe Clézardin
MiRNAs and snoRNAs in Bone Metastasis: Functional Roles and Clinical Potential. Cancers 15 (1) (2022)
Margherita Puppo, Manoj K Valluru, Philippe Clézardin
MicroRNAs and Their Roles in Breast Cancer Bone Metastasis. Current osteoporosis reports 19 (3) (2021)
Nico Hinz, Anke Baranowsky, Michael Horn, Malte Kriegs, Freya Sibbertsen, Daniel J Smit, Philippe Clézardin, Tobias Lange, Thorsten Schinke, Manfred Jücker
Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis. Cells 10 (2) (2021)
Cyrille B Confavreux, Helene Follet, David Mitton, Jean-Baptiste Pialat, Philippe Clézardin
Fracture Risk Evaluation of Bone Metastases: A Burning Issue. Cancers 13 (22) (2021)
Francesco Pantano, Martine Croset, Keltouma Driouch, Natalia Bednarz-Knoll, Michele Iuliani, Giulia Ribelli, Edith Bonnelye, Harriett Wikman, Sandra Geraci, Florian Bonin, Sonia Simonetti, Bruno Vincenzi, Saw See Hong, Sofia Sousa, Klaus Pantel, Giuseppe Tonini, Daniele Santini, Philippe Clézardin
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene 40 (7) (2021)
Mathilde Bouchet, Alexandra Lainé, Cyril Boyault, Mathilde Proponnet-Guerault, Emmanuelle Meugnier, Lamia Bouazza, Casina W S Kan, Sandra Geraci, Soumaya El-Moghrabi, Hector Hernandez-Vargas, Claire Benetollo, Yuji Yoshiko, Martine Duterque-Coquillaud, Philippe Clézardin, Julien C Marie, Edith Bonnelye
ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response. Cancer research 80 (13) (2020)
Margherita Puppo, Hanna Taipaleenmäki, Eric Hesse, Philippe Clézardin
Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance. British journal of pharmacology 178 (9) (2019)

Philippe Clézardin.css-eqlu8i{font-size:small;padding-left:4px;} (Philippe Clezardin)

Publication Activity (10 Years)

Top Topics

Top Venues

Philippe Clézardin (Philippe Clezardin)